Management of acute coronary syndromes: Assessing effectiveness;Tratamiento de los síndromes coronarios agudos: El conocimiento de la efectividad

Revista Espanola de Cardiologia

Volumn 57, Issue 4, 2004, Pages 275-278

  Permanyer Miralda, Gaietá ^a   Ferreira González, Ignacio ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN;

ANGIOCARDIOGRAPHY; COMORBIDITY; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; EDITORIAL; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; RISK BENEFIT ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 2942653010     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13059717     Document Type: Editorial

References (12)

1. Iezzoni LI. Risk adjustment for measuring healthcare outcomes. Ann Arbor: Healthcare Administration Press, 1997.
2. Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? J Am Coll Cardiol 2001;37:1827-35.
3. Gil M, Marrugat J, Sala J, Masià R, Elosua R, Albert X, et al. Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. Circulation 1999;99:1767-73.
4. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Bosch X, Rodríguez JJ, et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol 2003;56:1165-73.
5. Bosch X, López de Sá E, López Sendón J, Aboal J, Miranda-Guardiola F, Bethencourt A, et al. Perfil clí nico, pronóstico y variabilidad en el tratamiento del sí ndrome coronario agudo sin elevación del segmento ST. Dams del registro PEPA. Rev Esp Cardiol 2003;56:346-53.
6. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
7. Bosch X, Verbal F, López de Sá E, Miranda-Guardiola F, Bórquez E, Bethencourt A, et al. Diferencias en el tratamiento y la evolución clínica de los pacientes con síndrome coronario agudo sin elevación del segmento ST en función del servicio clínico de ingreso. Rev Esp Cardiol 2004;57:283-90.
8. Permanyer-Miralda G. Insuficiencia cardíaca: viejas preguntas, soluciones incompletas. Rev Esp Cardiol 2003;56:20-2.
9. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331:1136-42.
10. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001;110: 165-74.
11. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-9.
12. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J, et al. Improving quality of care for acute myocardial infarction. JAMA 2002;287:1321-3.